Longyu Li

Longyu Li

Auto-generated profile, based on publicly available information

Longyu Li

The First Affiliated Hospital of Zhengzhou University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2023 in Experimental Cell Research
Verified
Journal Article
Closed access
MLMingmei Li
Mingmei Li
LLLi Li
Li Li
XCXiaoxiao Cheng
Xiaoxiao Cheng
LLLongyu Li
Longyu Li
KTKaijia Tu
Kaijia Tu

3 September 2021 in Research Square
Verified
Preprint
Open access
PDF file
LLLongyu Li
Longyu Li
YSYifang Shi
Yifang Shi
NZNan Zhao
Nan Zhao
ZLZhengpei Liu
Zhengpei Liu
ZZZhe Zhao
Zhe Zhao
HLHongjian Liu
Hongjian Liu
Background Turner syndrome (TS) is characterized as the complete or partial absence of one X chromosome and is an extremely rare disease affecting approximately 1:2,500 live female births. Though the prevalence of osteoporosis among women with TS is estimated to be around 55-64% and they suffer more frequently from fractures than normal, few reports concerning TS patients with osteoporosis are able to be seen due to tiny number of patients. Case presentation Here we report a rare case of TS with osteoporosis, who has undergone percutaneous vertebroplasty (PVP) seven times because of several vertebral compression fractures (VCFs). G-banded karyotype analysis was performed and the result was 45,X[43]/47,XXX[17], indicating that the patient was a mosaicism of TS karyotype and Trisomy X syndrome karyotype. TS is the underlying cause of low level of estrogen for this patient. The interaction of aging, estrogen deficiency and intestinal dysbacteriosis leads to her severe osteoporosis and multi-segmental VCFs. The aim of this report is to provide recommendations regarding the management of TS patients with osteoporosis by reviewing the clinical presentation of TS, the influence of estrogen deficiency in osteoporosis, etc.Conclusions Early diagnosis and hormone replacement treatment are essential to prevent osteoporosis and reduce the risk of fractures. This is a rare case report describing TS patient with severe osteoporosis and VCFs.

11 April 2025
Verified
Preprint
Open access
ZWZhishuo Wang
Zhishuo Wang
JZJiaming Zhang
Jiaming Zhang
LLLongyu Li
Longyu Li
YZYuhao Zhang
Yuhao Zhang
CSChunfeng Shang
Chunfeng Shang
HLHongjian Liu
Hongjian Liu
Spinal cord injury (SCI) is a serious nervous system disease. After SCI, a series of cascade reactions will cause irreversible damage, and it has a high disability rate and death rate. The complexity of the pathologic mechanism of SCI limits the efficacy of various traditional therapies, and it is urgent to find new therapeutic means. In recent years, the method of extracting active ingredients from natural Chinese herbs to treat diseases has attracted a lot of attention. Polydatin (PD) is an active ingredient extracted from Polygonum polygonum, and its structure is similar to the traditional drug resveratrol. Sufficient studies have proved that PD plays anti-inflammatory, antioxidant, anti-apoptotic and neuroprotective roles in the treatment of multiple system diseases. These effects are also significant in the treatment of SCI. Based on the structural differences between PD and resveratrol, this paper illustrates the feasibility of using PD in the treatment of SCI, and systematically expounds the pathophysiological process of SCI and the molecular mechanism of PD in the treatment of SCI. In addition, several feasible strategies to improve PD yield and bioavailability are discussed, such as plant protection agent, material loading and drug combination.